Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Parkinson's disease Age: Adult Condition: As an adjunct to levodopa |
Dose: Tablet – 1-1.25 mg Frequency: at night Duration: 1st week |
|
Indication: Parkinson's disease Age: Adult Condition: As an adjunct to levodopa |
Dose: Tablet – 2-2.5 mg Frequency: at night Duration: 2nd week |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Hyperprolactinemia Age: 11-15 years Condition: Initially |
Dose: Oral Tablet – 1.25-2.5 mg Frequency: once daily Note: by mouth (oral) |
|
Indication: Hyperprolactinemia Age: 11-15 years Condition: Maintenance |
Dose: Oral Tablet – 2.5-10 mg/day Note: by mouth (oral) |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Dose: Note: Safety and efficacy has not been established |
Administration
- Should be taken with food
- Start with low dose
Side Effect
- Nausea (49%)
- Hypotension (30%)
- Headache (19%)
- Dizziness (17%)
- Abdominal cramps
- Anorexia
- Constipation
- Dyspepsia
- Dysphagia
- Epigastric pain
- GI hemorrhage
- Vomiting
- Drowsiness
- Fatigue
- Faintness
- Hallucinations Visual
- Insomnia
- Lightheadedness
- Nighmares
- Paranoia
- Psychosis
- Seizure
- Vertigo
- Arrhythmias
- Bradycardia
- Hypertension
- MI
- Mottled skin
- Orthostasis
- Vasospasm
- Palpitations
- Pericardial effusions
- Raynaud's syndrome exacertabtion
- Syncope
- Blepharospasm
- BUN increased
- Burning discomfort of the eye
- Diplopia
- Facial pallor
- Leg cramps
- Nasal congestion
- Rash
- Urticaria
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Erythromycin
|
Increased bioavailability
|
|
Alcohol
|
Reduces tolerance to bromocriptine and vice-versa
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Breast Carcinoma
|
Risk of tumor growth
|
|
Hypersensitivity to Ergot Alkaloids
|
Risk of severe allergic reaction
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Keep below 30°C temperature, away from light & moisture. Keep out of the reach of children.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.